Skip to main content
. 2011 Apr 13;11(Suppl 3):S26. doi: 10.1186/1471-2458-11-S3-S26

Figure 4.

Figure 4

The results of Stage II CHNRI process – an expert opinion exercise assessing the potential usefulness of investment in low-cost common protein pneumococcal vaccines